Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

DiLillo, David J, Tan, Gene S, Palese, Peter, Ravetch, Jeffrey V·2014·Nature Medicine

DOI 10.1038/nm.3443

Cited by (763)

Items 401–500 of 763

Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens
Anna Kirsteina, Ināra Akopjana, Jānis Bogans, I. Lieknina, Juris Jansons, Dace Skrastiņa, Tatjana Kazaka, Kaspars Tārs, Исакова-Сивак Ирина Николаевна, Daria А. Mezhenskaya et al. · 2020 · Vaccines
Development of broadly reactive influenza vaccines by targeting the conserved regions of the hemagglutinin stem and head domains
Nina M.C. De Jong, Aafke Aartse, Marit J. van Gils, Dirk Eggink · 2020 · Expert Review of Vaccines
Functional nucleic acids as modular components against SARS-CoV-2: From diagnosis to therapeutics
Wenxian Zhang, Na Liu, Jingjing Zhang · 2021 · Biosensors and Bioelectronics
Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo
Julia E. Edgar, Stephanie Trezise, Robert M. Anthony, Florian Krammer, Peter Palese, Jeffrey V. Ravetch, Stylianos Bournazos · 2023 · Proceedings of the National Academy of Sciences
Host genes and influenza pathogenesis in humans: an emerging paradigm
Kelvin Kai‐Wang To, Jie Zhou, Jasper Fuk‐Woo Chan, Kwok‐Yung Yuen · 2015 · Current Opinion in Virology
Mineralized State of the Avian Influenza Virus in the Environment
Hangyu Zhou, Guangchuan Wang, Xiaoyu Wang, Zhiyong Song, Ruikang Tang · 2017 · Angewandte Chemie International Edition
Bacillus toyonensis improves immune response in the mice vaccinated with recombinant antigen of bovine herpesvirus type 5
Francisco Denis Souza Santos, Yasmine Alves Menegon, Renan Eugênio Araujo Piraine, Paulo Ricardo Centeno Rodrigues, Rodrigo Casquero Cunha, Fábio Pereira Leivas Leite · 2017 · Beneficial Microbes
Poly-γ-Glutamic Acid Complexed With Alum Induces Cross-Protective Immunity of Pandemic H1N1 Vaccine
Quyen Thi Nguyen, Chaewon Kwak, Wang Sik Lee, Jaemoo Kim, Jinyoung Jeong, Moon‐Hee Sung, Jihyun Yang, Haryoung Poo · 2019 · Frontiers in Immunology
Is It Possible to Develop a “Universal” Influenza Virus Vaccine?
James E. Crowe · 2017 · Cold Spring Harbor Perspectives in Biology
Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life
Austin W. Boesch, Galit Alter, Margaret E. Ackerman · 2015 · Current Opinion in HIV and AIDS
Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?
Iván Sanz-Muñoz, Javier Sánchez‐Martínez, Carla Rodríguez-Crespo, Corina S. Concha-Santos, Marta Hernández, Silvia Rojo‐Rello, Marta Domínguez‐Gil, Ahmed Mostafa, Luis Martínez‐Sobrido, José María Eirós Bouza et al. · 2024 · mBio
Selective Engagement of FcγRIV by a M2e-Specific Single Domain Antibody Construct Protects Against Influenza A Virus Infection
Dorien De Vlieger, Katja Hoffmann, Inge Van Molle, Wim Nerinckx, Lien Van Hoecke, Marlies Ballegeer, Sarah Creytens, Han K. Remaut, Hartmut Hengel, Bert Schepens et al. · 2019 · Frontiers in Immunology
Flu Universal Vaccines: New Tricks on an Old Virus
Ruikun Du, Qinghua Cui, Lijun Rong · 2020 · Virologica Sinica
A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies
Cindy Bernelin‐Cottet, Charlotte Deloizy, Ondřej Staněk, Céline Barc, Edwige Bouguyon, Céline Urien, Olivier Boulesteix, Jérémy Pezant, Charles-Adrien Richard, Mohammed Moudjou et al. · 2016 · Frontiers in Immunology
Determination of antigenicity-altering patches on the major surface protein of human influenza A/H3N2 viruses
Christina Kratsch, Thorsten R. Klingen, Linda Mümken, Lars Steinbrück, Alice Carolyn McHardy · 2016 · Virus Evolution
An R848-Conjugated Influenza Virus Vaccine Elicits Robust Immunoglobulin G to Hemagglutinin Stem in a Newborn Nonhuman Primate Model
Elene A. Clemens, Beth C. Holbrook, Masaru Kanekiyo, Jonathan Wilson Yewdell, Barney S. Graham, Martha A. Alexander‐Miller · 2020 · The Journal of Infectious Diseases
Advances in influenza vaccination
Leslie A. Reperant, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus · 2014 · F1000Prime Reports
Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus
Miriam Klausberger, Rupert Tscheließnig, Silke Neff, Raffael Nachbagauer, Teddy John Wohlbold, Monika Wilde, Dieter Palmberger, Florian Krammer, Alois Jungbauer, Reingard Maria Grabherr · 2016 · PLoS ONE
Poor protective potential of influenza nucleoprotein antibodies despite wide prevalence
Hillary A. Vanderven, Robyn Esterbauer, Sinthujan Jegaskanda, Hyon‐Xhi Tan, Adam K. Wheatley, Stephen John Kent · 2021 · Immunology and Cell Biology
Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus
Fatima Amanat, Shirin Strohmeier, Philip S. Meade, Nicholas Dambrauskas, Barbara Mühlemann, Derek J. Smith, Vladimir I. Vigdorovich, D. Noah Sather, Lynda Coughlan, Florian Krammer · 2021 · PLoS Biology
Aptamer Blocking Strategy Inhibits SARS‐CoV‐2 Virus Infection
Miao Sun, Siwen Liu, Xinyu Wei, Shuang Wan, Mengjiao Huang, Ting Song, Yao Wei W Lu, Xiaonan Weng, Lin Zhu, Honglin Chen et al. · 2021 · Angewandte Chemie
Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination
Sarah M. Tete, Florian Krammer, Sarah Larteley Lartey, Geir Bredholt, John Wood, Steinar Skrede, Rebecca Jane Cox · 2016 · npj Vaccines
Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
Jin Hyang Kim, Adrian J. Reber, Amrita Kumar, Patricia Ramos, Gabriel Sica, Nedzad Music, Zhu Guo, Margarita Mishina, James Stevens, Ian A. York et al. · 2016 · Scientific Reports
Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses
Eugenio J. Abente, Daniela S. Rajão, Jefferson José da Silva Santos, Bryan S. Kaplan, Tracy L. Nicholson, Susan L. Brockmeier, Phillip Charles Gauger, Daniel Roberto Perez, Amy Louise Vincent · 2018 · Journal of Virology
Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles
Young‐Tae Lee, Ki‐Hye Kim, Eun‐Ju Ko, Min‐Chul Kim, Yuna Lee, Hye Suk Hwang, Youri Lee, Yu‐Jin Jung, Yu-Jin Kim, Jefferson José da Silva Santos et al. · 2019 · Virology
A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice
Susan Thrane, Kara-Lee Aves, Ida Elin Maria Uddback, Christoph Mikkel Janitzek, Julianna Han, Yuhe Renee Yang, Andrew B. Ward, Thor Grundtvig Theander, Morten Agertoug Nielsen, Ali Salanti et al. · 2020 · Vaccines
H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model
Juan Manuel Carreño, Shirin Strohmeier, Ericka Kirkpatrick Roubidoux, Rong Hai, Peter Palese, Florian Krammer · 2020 · mBio
Targeting Fc effector function in vaccine design
Simone I. Richardson, Penny L. Moore · 2021 · Expert Opinion on Therapeutic Targets
Microscale purification of antigen-specific antibodies
Eric P. Brown, Erica Normandin, Nana Yaw Osei‐Owusu, Alison E. Mahan, Ying N. Chan, Jennifer I. Lai, Monica Vaccari, Mangala Rao, Genoveffa Franchini, Galit Alter et al. · 2015 · Journal of Immunological Methods
Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection
Kelvin Kai‐Wang To, Jinxia Zhang, Andy Chan, Can Li, Jian‐Piao Cai, Candy C. Y. Lau, Chuangen Li, Akhee Sabiha Jahan, Wai‐Lan Wu, Lanjuan Li et al. · 2015 · Archives of Virology
Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A
Lynn H. Bimler, Sydney L. Ronzulli, Amber Y. Song, Scott K. Johnson, Cheryl A. Jones, Teha Kim, Duy Tri Le, Stephen Mark Tompkins, Silke Paust · 2020 · Journal of Virology
Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation
Jui‐Lin Chen, Chelsea N. Fries, Stella J. Berendam, Nicole S. Rodgers, Emily F. Roe, Yaoying Wu, Shuk Hang Li, Rishabh Jain, Brian E. Watts, Joshua Eudailey et al. · 2022 · Science Advances
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2
Phillip Pymm, Samuel J. Redmond, Olan Dolezal, Francesca L. Mordant, Ester López, James P. Cooney, Kathryn C. Davidson, Ebene R. Haycroft, Chee Wah Tan, Rebecca Seneviratna et al. · 2022 · iScience
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection
Daria V. Voronina, Dmitry V. Shcheblyakov, Irina A. Favorskaya, Ilias B. Esmagambetov, Alina Sh. Dzharullaeva, Тухватулин Амир Ильдарович, Olga V. Zubkova, Olga D. Popova, Vladislav Y. Kan, Банделюк Алина Сергеевна et al. · 2022 · Viruses
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein
Carly M. Bliss, Raffael Nachbagauer, Chiara Mariottini, Frans Cuevas, Jodi Feser, Abdi Naficy, David I. Bernstein, Jeffrey T. Guptill, Emmanuel B. Walter, Francesco Berlanda Scorza et al. · 2024 · EBioMedicine
Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection
Yo Han Jang, Baik Lin Seong · 2020 · Expert Opinion on Drug Discovery
Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection
Fan Zhou, Lena Hansen, Gabriel Kristian Pedersen, Gunnveig Grødeland, Rebecca Jane Cox · 2021 · Frontiers in Immunology
Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus
Philipp Kolb, Steven Sijmons, Matthew R. McArdle, Husam Taher, Jennie L. Womack, Colette M. Hughes, Abigail B. Ventura, Michael A. Jarvis, Christiane Stahl‐Hennig, Scott G. Hansen et al. · 2018 · Journal of Virology
Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate
Juan Manuel Carreño, Hala Alshammary, Johnstone Tcheou, Gagandeep Singh, Ariel J. Raskin, Hisaaki Kawabata, Levy A. Sominsky, Jordan J. Clark, Daniel C. Adelsberg, Dominika A. Bielak et al. · 2021 · medRxiv
Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters
Wen Su, Sin Fun Sia, Aaron J. Schmitz, Traci L. Bricker, Tyler N. Starr, Allison J. Greaney, Jackson S. Turner, Bassem M. Mohammed, Zhuoming Liu, Ka Tim Choy et al. · 2021 · mBio
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
Branislav Kováčech, Ľubica Fialová, Peter Filipčík, Rostislav Škrabana, Monika Žilková, Natalia Paulenka Ivanovova, Andrej Kováč, Denisa Palova, Gabriela Rolkova, Katarina Tomkova et al. · 2022 · EBioMedicine
Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies
Anna Roos, Ramon Roozendaal, Theeuwsen Jessica, Sarra Riahi, Joost Vaneman, Jeroen T. B. M. Tolboom, Liesbeth Dekking, Wouter Koudstaal, Jaap Goudsmit, Katarina Radošević · 2015 · Vaccine
Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins
Henju Marjuki, Vasiliy P. Mishin, Ning Chai, Man‐Wah Tan, Elizabeth M. Newton, John Tegeris, Karl J. Erlandson, Melissa Swope Willis, Joyce E. Jones, Todd C. Davis et al. · 2016 · Journal of Virology
Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection
Yu-Jin Kim, Eun‐Ju Ko, Min‐Chul Kim, Yuna Lee, Ki‐Hye Kim, Yu‐Jin Jung, Sang‐Moo Kang · 2017 · Biochemical and Biophysical Research Communications
Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations
Synnøve Eidem, Sarah M. Tete, Åsne Jul‐Larsen, Katja Höschler, Emanuele Montomoli, Karl Albert Brokstad, Rebecca Jane Cox · 2015 · Vaccine
Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults
Fernanda Ana‐Sosa‐Batiz, Angus P. R. Johnston, Philip Mark Hogarth, Bruce D. Wines, Ian Barr, Adam K. Wheatley, Stephen John Kent · 2017 · Vaccine
Serum IgM Glycosylation Associated with Tuberculosis Infection in Mice
Tadahiro Kumagai, Ainhoa Palacios, Arturo Casadevall, María Jesús García García, Carlos Toro, Michael Tiemeyer, Rafael Prados‐Rosales · 2019 · mSphere
Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
Ariel Isaacs, Zheyi Li, Stacey T. M. Cheung, Danushka K. Wijesundara, Christopher L. D. McMillan, Naphak Modhiran, Paul R. Young, Charani Ranasinghe, Daniel Watterson, Keith Joseph Chappell · 2021 · Vaccines
Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head
Manxue Jia, H T Zhao, Nicholas C. Morano, Hong Lu, Yin-Ming Lui, Haijuan Du, Jordan E. Becker, Kwok‐Yung Yuen, David D. Ho, Peter D. Kwong et al. · 2024 · Nature Communications
Universal influenza vaccines: a realistic option?
Rory D. de Vries, Arwen F. Altenburg, Guus F. Rimmelzwaan · 2016 · Clinical Microbiology and Infection
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination
Teresa Aydillo, Ana Silvia Gonzalez-Reiche, Daniel Stadlbauer, Mary Anne S. Amper, Venugopalan D. Nair, Chiara Mariottini, Stuart C. Sealfon, Harm van Bakel, Peter Palese, Florian Krammer et al. · 2022 · npj Vaccines
B cells secrete functional antigen-specific IgG antibodies on extracellular vesicles
Claudia M. Rival, Mahua Mandal, Kayla Cramton, Hui Qiao, Mohd Arish, Jie Sun, James V. McCann, Andrew C. Dudley, Michael D. Solga, Uta Erdbrügger et al. · 2024 · Scientific Reports
Cross-protective efficacies of highly-pathogenic avian influenza H5N1 vaccines against a recent H5N8 virus
Su-Jin Park, Young‐Jae Si, Jihye Kim, Min‐Suk Song, Se Mi Kim, Eun-Ha Kim, Hyeok-il Kwon, Young‐Il Kim, Ok-Jun Lee, Ok Sarah Shin et al. · 2016 · Virology
A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection
Takuya Yamamoto, Yuji Masuta, Masatoshi Momota, Masaru Kanekiyo, Tomohiro Kanuma, Shokichi Takahama, Eiko Moriishi, Yasuhiro Yasutomi, Takashi Saito, Barney S. Graham et al. · 2018 · International Immunology
Peste des Petits Ruminants Virus Fusion and Hemagglutinin Proteins Trigger Antibody-Dependent Cell-Mediated Cytotoxicity in Infected Cells
José Manuel Rojas, Daniel Rodríguez-Martín, Miguel Avia, Verónica Martı́n, Noemı́ Sevilla · 2019 · Frontiers in Immunology
Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination
Shahinul Islam, Fan Zhou, Sarah Larteley Lartey, Kristin Greve-Isdahl Mohn, Florian Krammer, Rebecca Jane Cox, Karl Albert Brokstad · 2019 · Scandinavian Journal of Immunology
Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity
Adam K. Wheatley, Stephen John Kent · 2015 · Expert Review of Vaccines
A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza
Boopathy Ramakrishnan, Karthik Viswanathan, Kannan Tharakaraman, Vlado Dančík, Rahul Raman, Gregory J. Babcock, Zachary H. Shriver, Ram Sasisekharan · 2016 · Trends in Microbiology
Cytotoxic IgG: Mechanisms, functions, and applications
Miriam Wöhner, Falk Nimmerjahn · 2025 · Immunity
Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus
Seiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, Ryuta Uraki, Yoshihiro Kawaoka · 2018 · Journal of Clinical Virology
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses
Christopher L. D. McMillan, Stacey T. M. Cheung, Naphak Modhiran, James Barnes, Alberto Anastacio Amarilla, Helle Bielefeldt‐Ohmann, Leo Lee, Kate A. Guilfoyle, Geert van Amerongen, Koert J. Stittelaar et al. · 2021 · npj Vaccines
ADCC: An underappreciated correlate of cross-protection against influenza?
Rory D. de Vries, Katja Höschler, Guus F. Rimmelzwaan · 2023 · Frontiers in Immunology
Protective efficacy of a universal influenza mRNA vaccine against the challenge of H1 and H5 influenza A viruses in mice
Yulei Li, Xi Wang, Xi Zeng, Wenbo Ren, Pu Liao, Baoli Zhu · 2023 · mLife
Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza disease
Zhaochen Luo, Hector A. Miranda, Kaitlyn N. Burke, M. Ariel Spurrier, Madison Berry, Erica L. Stover, Rachel L. Spreng, Greg M. Waitt, Erik J. Soderblom, Andrew N. Macintyre et al. · 2024 · Science Translational Medicine
A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques
Kelsey R. Florek, Attapon Kamlangdee, James P. Mutschler, Brock A. Kingstad-Bakke, NANCY J. SCHULTZ‐DARKEN, Karl W. Broman, Jorge E. Osorio, Thomas C. Friedrich · 2017 · PLoS ONE
An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge
Jason R. Wilson, Jessica A. Belser, Juliana C. DaSilva, Zhu Guo, Xiangjie Sun, Shane Gansebom, Yaohui Bai, Thomas J. Stark, Jessie C. Chang, Paul J. Carney et al. · 2017 · Virology
HEV ORF3 downregulatesCD14 and CD64 to impair macrophages phagocytosis through inhibiting JAK/STAT pathway
Qingsong Lei, Li Lin, Wenxiang Huang, Bo Qin, Shujun Zhang · 2019 · Journal of Medical Virology
Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates
Jessica A. Flynn, Teresa Weber, Pedro Joel Cejas, Kara S. Cox, Sinoeun Touch, Lauren A. Austin, Yangsi Ou, Michael P. Citron, Bin Luo, Marian E. Gindy et al. · 2022 · Vaccine
Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions
Ali Zhang, Hanu Chaudhari, Yonathan Agung, Michael R. D’Agostino, Jann Catherine Ang, Yona Tugg, Matthew S. Miller · 2022 · Cell Reports Medicine
Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza
Ane Marie Anderson, Marta Baranowska-Hustad, Ranveig Braathen, Gunnveig Grødeland, Bjarne Bogen · 2018 · The Journal of Immunology
A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses
Holly C. Simmons, Akiko Watanabe, Thomas H. Oguin, Elizabeth S. Van Itallie, Kevin J. Wiehe, Gregory D. Sempowski, Masayuki Kuraoka, Garnett H. Kelsoe, Kevin R. McCarthy · 2023 · PLoS Biology
Antibody‐mediated control mechanisms of viral infections
Samantha Mackin, Alan Sariol, Michael Diamond · 2024 · Immunological Reviews
Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human
Seiya Yamayoshi, Mutsumi Ito, Ryuta Uraki, Tadahiro Sasaki, Kazuyoshi Ikuta, Yoshihiro Kawaoka · 2017 · Journal of Infection
Development of a Macrophage-Based ADCC Assay
Melissa B. Uccellini, Sadaf Aslam, Sean T. H. Liu, Fahmida Alam, Adolfo García‐Sastre · 2021 · Vaccines
A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination
Melissa M. Lemke, Milla R. McLean, Christina Y. Lee, Ester López, Emily R. Bozich, Supachai Rerks‐Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Sven Kratochvil, Bruce D. Wines et al. · 2021 · Cell Reports Medicine
Synergistic effect of non-neutralizing antibodies and interferon-γ for cross-protection against influenza
Meito Shibuya, Shigeyuki Tamiya, Atsushi Kawai, Toshiro Hirai, Mark Steven Cragg, Yasuo Yoshioka · 2021 · iScience
LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection
Falk Nimmerjahn, Anja Lux · 2014 · Proceedings of the National Academy of Sciences
Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies
Meret E. Ricklin, Nathalie Jane Vielle, Sylvie Python, Daniel Brechbühl, Béatrice Zumkehr, Horst Posthaus, Gert Zimmer, Artur Summerfield · 2016 · Frontiers in Immunology
Induction of peripheral blood T follicular helper cells expressing ICOS correlates with antibody response to hepatitis B vaccination
Mingluan Xing, Yonghui Feng, Jun Yao, Huakun Lv, Yongdi Chen, Hanqing He, Zhifang Wang, Chonggao Hu, Xiaoming Lou · 2019 · Journal of Medical Virology
A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, Jun Siong Low, M. Alejandra Tortorici, Michael Patrick Housley, Julia Noack, Alexandra C. Walls, John E. Bowen, Barbara Guarino et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
A Complex Dance: Measuring the Multidimensional Worlds of Influenza Virus Evolution and Anti-Influenza Immune Responses
Jiong Wang, Alexander Wiltse, Martin Stuart Zand · 2019 · Pathogens
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Ruth A Purcell, Robert M. Theisen, Kelly B. Arnold, Amy W. Chung, Kevin John Selva · 2023 · Frontiers in Immunology
Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins
Jenna J. Guthmiller, Linda Yu-Ling Lan, Lie Li, Yanbin Fu, Sean A. Nelson, Carole Henry, Christopher T. Stamper, Henry A. Utset, Alec W. Freyn, Julianna Han et al. · 2025 · Immunity
Evasión de la respuesta inmune por virus herpes simplex
Angello R Retamal-Díaz, Paula A. Suazo, Ignacio Garrido, Alexis M. Kalergis, Pablo A. González · 2015 · Revista chilena de infectología
Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant
Crina Stăvaru, Adrian Onu, Emilia Lupulescu, Cătălin Ţucureanu, Orhan Raşid, Ene Vlase, Cristin Coman, Iuliana Caraș, Alina Ghiorghisor, Laurentiu Berbecila et al. · 2015 · Human Vaccines & Immunotherapeutics
A monoclonal antibody with anti‐D–like activity in murine immune thrombocytopenia requires Fc domain function for immune thrombocytopenia ameliorative effects
Xiaojie Yu, Melissa Menard, Gemma E. Seabright, Max Crispin, Alan H. Lazarus · 2015 · Transfusion
Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus
Mutsumi Ito, Seiya Yamayoshi, Kazushi Murakami, Kenji Saito, Atsuo Motojima, Kazunari Nakaishi, Yoshihiro Kawaoka · 2019 · Viruses
Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection
Kathie‐Anne Walters, Ruoqing Zhu, Michael E. Welge, Kelsey Scherler, Jae-Keun Park, Zainab Rahil, Hao Wang, Loretta Sue Auvil, Colleen Bushell, Min Young Lee et al. · 2019 · mBio
Mature Dendritic Cell-Derived Extracellular Vesicles are Potent Mucosal Adjuvants for Influenza Hemagglutinin Vaccines
Chunhong Dong, Lai Wei, Wandi Zhu, Joo Kyung Kim, Ye Wang, Priscilla Omotara, Arini Arsana, Bao‐Zhong Wang · 2025 · ACS Nano
Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice
Robert E. Haupt, Lauren Baracco, Erin M. Harberts, Madhumathi Loganathan, Lucas J. Kerstetter, Florian Krammer, Lynda Coughlan, Robert K. Ernst, Matthew B. Frieman · 2023 · Scientific Reports
Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes
Dustin M. McCraw, Mallory L. Myers, Neetu M. Gulati, Madhu S. Prabhakaran, Joshua Brand, Sarah F. Andrews, John R. Gallagher, Samantha Maldonado-Puga, Alexander J. Kim, Udana Torian et al. · 2023 · PLoS Pathogens
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
Laura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, Mireya L. Borrajo, Gustavo Lou, Lorenzo Franceschini, Ignasi Esteban, Pedro J. Sánchez‐Cordón, Carmen Zamora, Carlos Óscar S. Sorzano et al. · 2024 · npj Vaccines
Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination
Boitumelo M. Motsoeneng, Nisha Dhar, Marta Coelho Nunes, Florian Krammer, Shabir Ahmed Madhi, Penny L. Moore, Simone I. Richardson · 2024 · The Journal of Infectious Diseases
The function of antibodies
Marc Daëron · 2024 · Immunological Reviews
Pre-exposure antibody prophylaxis protects macaques from severe influenza
Masaru Kanekiyo, Rebecca A. Gillespie, Kristine L. Cooper, Vanessa I. Guerra, Priscila M. S. Castanha, Amarendra Pegu, Eun Sung Yang, Luke Treaster, Gabin Yun, Megan Wallace et al. · 2025 · Science
T and B cell responses in different immunization scenarios for COVID-19: a narrative review
Eva Piano Mortari, Francesca Ferrucci, Irini Zografaki, Rita Carsetti, Luciano Pacelli · 2025 · Frontiers in Immunology
Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza
John H. Beigel, David Oldach · 2025 · The Journal of Infectious Diseases
Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells
Freek Cox, Matthijs Baart, Jeroen Huizingh, Jeroen T. B. M. Tolboom, Liesbeth Dekking, Jaap Goudsmit, Eiríkur Saeland, Katarina Radošević · 2015 · PLoS ONE
Cell-targeting antibodies in immunity to Ebola
Alan L. Schmaljohn, George K. Lewis · 2016 · Pathogens and Disease
Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody
Veronika Chromikova, Maria A. Zaragoza, Florian Krammer · 2017 · PLoS ONE